新闻稿
TherVacB Project Begins Patient Trial to Advance Curative Strategy for Chronic Hepatitis B
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and contributing to over one million deaths each year through liver failure and liver cancer.
Hope for Hepatitis B patients
New research project to cure hepatitis B patients under the European Horizon 2020 programme.
项目徽标
下载 TherVacB 徽标:此处